Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Mesalazine may help treat extensive alopecia areata effectively.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

New treatments focusing on immune pathways show promise for stubborn hair loss.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.